Spain
Bioquim S.A., known for its slogan "European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis," presents a compelling opportunity for investors targeting the pharmaceutical manufacturing space.
Founded in 1979 and headquartered in Spain, this company boasts over four decades of experience in producing bulk oral and sterile Active Pharmaceutical Ingredients (APIs) for both human and veterinary markets. Bioquim has established itself as a reliable partner, specializing in high-quality corticosteroids, peptides, amino acids, penicillin derivatives, non-penicillin antibiotics, and HPAPIs.
Operating under stringent Good Manufacturing Practices (GMP), the company utilizes state-of-the-art facilities and advanced technology, ensuring compliance with the highest industry standards. Bioquim's offerings are further enhanced by its Custom Synthesis and Contract Manufacturing services, providing tailored solutions in sterile APIs.
Despite its showcased expertise and robust infrastructure, Bioquim S.A. has not reported recent investment rounds, making this a potential area for incoming investors to explore and capitalize on.
